The FDA has even permitted a drug produced with cannabidiol for that objective (Epidiolex). Even so the company only recommends it for two unusual varieties of childhood epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they plan to reclassify cannabis being a Agenda